on January 3, 2006
Published online before print January 3, 2006, doi: 10.1161/01.HYP.0000197950.42301.dd
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 30, 2005
From the Department of Physiology and Biophysics, Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Miss. * To whom correspondence should be addressed. E-mail: jgranger{at}physiology.umsmed.edu.
Abstract--The initiating event in preeclampsia is thought be to reduced uteroplacental perfusion. Although we have reported previously that chronic reductions in uterine perfusion pressure (RUPP) in pregnant rats results in hypertension and enhanced endothelin production, the factors linking placental ischemia and endothelial cell activation remain unclear. The purpose of this study was to determine the role of angiotensin II type-1 (AT1) receptor activation on endothelin production induced by serum from pregnant rats exposed to reductions in uterine perfusion. To achieve this goal, human umbilical vein endothelial cells were exposed to sera collected from RUPP rats or normal pregnant rats. Arterial pressure was significantly higher in RUPP rats (135±2 mm Hg) than in pregnant rats (106±1 mm Hg). Six hours after exposure to RUPP serum (n=17), cell media endothelin concentration was 18.4±2.7 pg/mL as compared with 9.22±1.3 pg/mL from cells exposed to serum from normal pregnant rats (n=9). Eighteen hours after exposure to RUPP serum (n=7), endothelin concentration was 30.5±3.8 pg/mL as compared with 12.8±5.3 pg/mL from cells exposed to normal pregnant rat serum (n=6). In contrast, serum from RUPP rats did not increase endothelin production in human umbilical vein endothelial cells pretreated with an AT1 receptor antagonist, losartan (15 µmol/L). Eighteen hours after exposure to RUPP serum and losartan (n=14), endothelin concentration was 21.3±2.2 pg/mL as compared with 16.4±3.3 pg/mL from cells exposed to normal pregnant rat serum and losartan (n=10). These data indicate that serum from pregnant rats exposed to reductions in uterine perfusion enhances endothelin production by endothelial cells via by AT1 receptor activation.
Revised on October 19, 2005
Enhanced Endothelin Synthesis by Endothelial Cells Exposed to Sera From Pregnant Rats With Decreased Uterine Perfusion
Lyndsay Roberts;
Key words: pregnancy, hypertension • angiotensin II • endothelin
This article has been cited by other articles:
 |
|
 |
|
  B. LaMarca, M. Parrish, L. F. Ray, S. R. Murphy, L. Roberts, P. Glover, G. Wallukat, K. Wenzel, K. Cockrell, J. N. Martin Jr, et al. Hypertension in Response to Autoantibodies to the Angiotensin II Type I Receptor (AT1-AA) in Pregnant Rats: Role of Endothelin-1 Hypertension, October 1, 2009; 54(4): 905 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Walsh, F. A. English, E. J. Johns, and L. C. Kenny Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization Hypertension, August 1, 2009; 54(2): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. LaMarca, J. Speed, L. Fournier, S. A. Babcock, H. Berry, K. Cockrell, and J. P. Granger Hypertension in Response to Chronic Reductions in Uterine Perfusion in Pregnant Rats: Effect of Tumor Necrosis Factor-{alpha} Blockade Hypertension, December 1, 2008; 52(6): 1161 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Collino, B. Bussolati, E. Gerbaudo, L. Marozio, S. Pelissetto, C. Benedetto, and G. Camussi Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1185 - F1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gilbert, S. A. Babcock, and J. P. Granger Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression Hypertension, December 1, 2007; 50(6): 1142 - 1147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xia, C. C. Zhou, S. M. Ramin, and R. E. Kellems Angiotensin Receptors, Autoimmunity, and Preeclampsia J. Immunol., September 15, 2007; 179(6): 3391 - 3395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xia, S. M. Ramin, and R. E. Kellems Potential Roles of Angiotensin Receptor-Activating Autoantibody in the Pathophysiology of Preeclampsia Hypertension, August 1, 2007; 50(2): 269 - 275. [Full Text] [PDF]
|
|
|
|
|
|
S. T. Chelbi, F. Mondon, H. Jammes, C. Buffat, T.-M. Mignot, J. Tost, F. Busato, I. Gut, R. Rebourcet, P. Laissue, et al. Expressional and Epigenetic Alterations of Placental Serine Protease Inhibitors: SERPINA3 Is a Potential Marker of Preeclampsia Hypertension, January 1, 2007; 49(1): 76 - 83. [Abstract] [Full Text] [PDF]
|
|